29. Mechanism of Action (MOA)
1. Corneal repair 2. Anti-apoptosis
TF: transcription factors
3. Tear quality
via MGD, mucin
30. Staining score of 9 areas
Score: 0~4
Corneal Staining Scores between placebo and anti-miR-328
Liao et al. J Ocul Pharmacol Ther. 2022 Mar;38(2):125-132
乾眼症角膜破皮染色
31. Dose-dependent effect of anti-miR-328
1x 3x 6x 9x
On Day 14 after different doses (uM) of anti-miR-328 + 0.2% BAC
12x 16x
Liao et al. J Ocul Pharmacol Ther. 2022 Mar;38(2):125-132
34. PBS Tx
Hyperkeratosis
Anti-miR-328 Tx
Anti-miR-328 reduces keratosis in Meibomian gland
orifice of rabbits
Liao et al. J Ocul Pharmacol Ther. 2022 Mar;38(2):125-132
新藥水Anti-miR-328治療修復
減少乾眼症油脂腺眼瞼板角質化阻塞
35. MOA: anti-miR-328 treatment increases mucin5AC expression in the eye
新藥水Anti-miR-328治療增加淚水成分黏蛋白mucin分泌
Anti-miR-328 increases goblet cells by impression cytology
36. Efficacy Safety
Ease Comfort
Efficacy
Better than
Restasis
Convenience
Two instillation
daily
Safety
High safety profiles:
based on human
trial and animal data
No irritation
No discomfort to
the eye or mouth
SHJ002 is better than Restasis in DED
新藥水Anti-miR-328治療乾眼症實驗優於目前臨床乾眼症用藥